Roche touts drugs pipeline, rules out Merger and Acquisition just to boost sales Medical Dialogues Bureau7 Sept 2019 9:15 AM ISTRoche has twice upgraded 2019 sales forecasts, the latest time to mid- to high-single-digit percentage rate growth, as medicines including Ocrevus for...
Roche names Eli Lilly executive Levi Garraway as chief medical officer Medical Dialogues Bureau20 Aug 2019 9:00 AM ISTLevi Garraway, most recently Eli Lilly's senior vice president, oncology research and development and Lilly research laboratories novel target...
Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month Medical Dialogues Bureau17 Aug 2019 9:15 AM ISTRozlytrek was approved by the U.S. Food and Drug Administration on Thursday to treat certain types of solid tumours, which show rare genetic anomalies...
Sanofi strikes deal for US rights to Roche Tamiflu Medical Dialogues Bureau24 July 2019 9:15 AM ISTUnder the terms of the agreement, Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing,...
Single dose of Xofluza flu drug as effective as Tamiflu in kids, says Roche Medical Dialogues Bureau6 July 2019 9:15 AM ISTXofluza, an oral treatment, was well tolerated in children, said Roche, whose medicine is already approved broadly in Japan and for people older than...
Roche wins Japan approval for personalised cancer drug Rozlytrek Medical Dialogues Bureau19 Jun 2019 12:01 PM ISTZURICH: Swiss drugmaker Roche on Tuesday won approval in Japan for Rozlytrek as the world's biggest maker of cancer drugs pushes ahead in personalised...
Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit Medical Dialogues Bureau12 Jun 2019 9:30 AM ISTRoche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
Roche gets USFDA nod for combo lymphoma treatment Polivy Medical Dialogues Bureau11 Jun 2019 9:30 AM ISTPolivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...
Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny Farhat Nasim10 Jun 2019 9:30 AM ISTRoche said on Monday that both companies received a request for more information from the U.S. Federal Trade Commission in connection with the FTC's...
Roche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer care Medical Dialogues Bureau3 Jun 2019 9:45 AM ISTThe new version of NAVIFY Tumor Board is initially available in the United States and Canada with additional markets to follow in the near future.New...
Roche gets USFDA nod for combo drug Venclexta, Gazyva to treat lymphocytic leukaemia Medical Dialogues Bureau17 May 2019 9:15 AM IST"Venclexta plus Gazyva is the only chemotherapy-free option of fixed duration that provides durable responses to help people live longer without...
AstraZeneca ties up with Transgene to develop viral immunotherapies Garima2 May 2019 9:25 AM ISTAstraZeneca has been moving deeper into cancer therapy market through wide-ranging deals, including those for immunotherapy and targeted therapy.New...
